Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Scand J Gastroenterol ; 54(5): 623-632, 2019 May.
Article in English | MEDLINE | ID: mdl-31067143

ABSTRACT

The macrophage activation markers, soluble CD163 (sCD163) and soluble mannose receptor (sMR), are associated with liver disease severity and prognosis. We aimed to investigate macrophage activation reflected by sMR and sCD163 in patients with mild and severe paracetamol (PCM) intoxication and effects of antidote treatment in patients and healthy controls. We measured sMR and sCD163 levels by in-house enzyme-linked immunosorbent assays in two independent prospective cohorts of PCM overdosed patients: 49 patients with early mild PCM overdose from Aarhus University Hospital and 30 patients with severe acute liver injury included at the Royal Infirmary of Edinburgh. Furthermore, we investigated sMR and sCD163 in 14 healthy controls during N-acetylcysteine treatment. Within the mild PCM cohort, patients with elevated alanine transaminase on admission had significantly higher levels of sCD163 compared with patients with normal alanine transaminase (2.92[2.00-5.75] versus 1.29[1.02-1.69] mg/L, p = .009), whereas sMR showed no significant difference. In patients with acute liver injury, both markers were markedly higher compared to the mild PCM cohort (sCD163: 10.73[5.79-14.62] versus 1.34[1.06-1.96], p < .001; sMR: 0.80[0.63-1.14] versus 0.18[0.14-0.25], p < .001). Antidote treatment significantly reduced sCD163 levels in both PCM overdosed patients and healthy controls. In conclusion, macrophage activation assessed by the levels of sMR and sCD163 is associated with the degree of liver injury in patients with PCM intoxication and is ameliorated by antidote treatment, suggesting macrophage involvement in PCM-induced liver injury.


Subject(s)
Acetaminophen/poisoning , Analgesics, Non-Narcotic/poisoning , Antigens, CD/blood , Antigens, Differentiation, Myelomonocytic/blood , Chemical and Drug Induced Liver Injury/blood , Lectins, C-Type/blood , Macrophage Activation , Mannose-Binding Lectins/blood , Receptors, Cell Surface/blood , Adult , Antidotes/therapeutic use , Antigens, CD/drug effects , Antigens, Differentiation, Myelomonocytic/drug effects , Biomarkers/blood , Case-Control Studies , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/etiology , Drug Overdose/therapy , Female , Humans , Lectins, C-Type/drug effects , Linear Models , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Middle Aged , Prognosis , Prospective Studies , Receptors, Cell Surface/drug effects , Young Adult
2.
JCI Insight ; 3(1)2018 01 11.
Article in English | MEDLINE | ID: mdl-29321379

ABSTRACT

Hypoglycemia is commonly associated with insulin therapy, limiting both its safety and efficacy. The concept of modifying insulin to render its glucose-responsive release from an injection depot (of an insulin complexed exogenously with a recombinant lectin) was proposed approximately 4 decades ago but has been challenging to achieve. Data presented here demonstrate that mannosylated insulin analogs can undergo an additional route of clearance as result of their interaction with endogenous mannose receptor (MR), and this can occur in a glucose-dependent fashion, with increased binding to MR at low glucose. Yet, these analogs retain capacity for binding to the insulin receptor (IR). When the blood glucose level is elevated, as in individuals with diabetes mellitus, MR binding diminishes due to glucose competition, leading to reduced MR-mediated clearance and increased partitioning for IR binding and consequent glucose lowering. These studies demonstrate that a glucose-dependent locus of insulin clearance and, hence, insulin action can be achieved by targeting MR and IR concurrently.


Subject(s)
Glucose/metabolism , Hypoglycemia/drug therapy , Insulin/pharmacology , Animals , Antigens, CD , Blood Glucose , Cell Line , Diabetes Mellitus, Type 2 , Disease Models, Animal , Hypoglycemic Agents/pharmacology , Lectins, C-Type/drug effects , Liver/pathology , Macrophages , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mice , Mice, Inbred C57BL , Rats , Receptor, Insulin/drug effects , Receptors, Cell Surface/drug effects
3.
Fertil Steril ; 107(1): 167-173.e2, 2017 01.
Article in English | MEDLINE | ID: mdl-27793384

ABSTRACT

OBJECTIVES: To characterize peritoneal dendritic cells (DCs) in endometriosis and to clarify their role in its etiology. DESIGN: Experimental. SETTING: University hospital. PATIENT(S): Sixty-three women (35 patients with endometriosis and 28 control women) who had undergone laparoscopic surgery. INTERVENTION(S): Peritoneal DCs from endometriosis and control samples were analyzed for the expression of cell surface markers. Monocyte-derived dendritic cells (Mo-DCs) were cultured with dead endometrial stromal cells (dESCs) to investigate changes in phagocytic activity and cytokine expression. MAIN OUTCOME MEASURE(S): Cell surface markers and cytokine expression and identification with the use of flow cytometry or reverse-transcription polymerase chain reaction (RT-PCR). Changes in cytokine expression and phagocytic activity of Mo-DCs cultured with dESCs and d-mannan were measured with the use of flow cytometry and RT-PCR. RESULT(S): The proportion of mannose receptor (MR)-positive myeloid DC type 1 was higher in endometriosis samples than in control samples. The blocking of MR reduced phagocytosis of dESCs by Mo-DCs. Mo-DCs cultured with dESCs expressed higher levels of interleukin (IL) 1ß and IL-6 than control samples. CONCLUSION(S): Peritoneal DCs in endometriosis tissue express high levels of MR, which promotes phagocytosis of dead endometrial cells and thereby contributes to the etiology of endometriosis.


Subject(s)
Dendritic Cells/metabolism , Endometriosis/metabolism , Lectins, C-Type/metabolism , Mannose-Binding Lectins/metabolism , Receptors, Cell Surface/metabolism , Case-Control Studies , Cells, Cultured , Coculture Techniques , Dendritic Cells/drug effects , Dendritic Cells/immunology , Endometriosis/diagnosis , Endometriosis/immunology , Endometriosis/pathology , Female , Hospitals, University , Humans , Inflammation Mediators/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Lectins, C-Type/drug effects , Mannans/pharmacology , Mannose Receptor , Mannose-Binding Lectins/drug effects , Peritoneal Cavity/cytology , Phagocytosis , Receptors, Cell Surface/drug effects , Stromal Cells/immunology , Stromal Cells/pathology
4.
Andrology ; 3(6): 1068-75, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26445132

ABSTRACT

In a recent study, lactoferrin (LF) was detected in human oviductal secretion. The protein was able to bind to oocytes and sperm, and modulated gamete interaction. The aim of the present study was to investigate the effect of LF on parameters related to human sperm capacitation and sperm-zona pellucida interaction. Semen samples were obtained from healthy normozoospermic donors (n = 7). Human follicular fluids and oocytes were collected from patients undergoing in vitro fertilization. Motile sperm obtained by swim-up were incubated for 6 or 22 h under capacitating conditions with LF (0-100 µg/mL). After incubations, viability, motility, presence of α-d-mannose receptors (using a fluorescent probe on mannose coupled to bovine serum albumin), spontaneous and induced acrosome reaction (assessed with Pisum sativum agglutinin conjugated to fluorescein isothiocyanate), and tyrosine phosphorylation of sperm proteins were evaluated. Sperm-zona pellucida interaction in the presence of LF was investigated using the hemizone assay. The presence of LF did not affect sperm viability or motility, but caused a dose-dependent significant decrease in sperm α-d-mannose-binding sites, and the effect was already significant with the lowest concentration of the protein used after 22 h incubation. Dose-dependent significant increases in both induced acrosome reaction and tyrosine phosphorylation of sperm proteins were observed in the presence of LF. The present data indicate that LF modulates parameters of sperm function. The inhibition of gamete interaction by LF could be partially explained by the decrease in sperm d-mannose-binding sites. The presence of the LF promoted sperm capacitation in vitro.


Subject(s)
Lactoferrin/pharmacology , Oocytes/drug effects , Sperm Capacitation/drug effects , Sperm-Ovum Interactions/drug effects , Spermatozoa/drug effects , Acrosome Reaction/drug effects , Cell Survival/drug effects , Cells, Cultured , Coculture Techniques , Dose-Response Relationship, Drug , Female , Humans , Lactoferrin/metabolism , Lectins, C-Type/drug effects , Lectins, C-Type/metabolism , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mannose-Binding Lectins/metabolism , Oocytes/metabolism , Phosphorylation , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/metabolism , Signal Transduction/drug effects , Sperm Motility/drug effects , Spermatozoa/metabolism , Time Factors , Tyrosine , Young Adult
5.
Pharm Res ; 32(8): 2663-77, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25715698

ABSTRACT

PURPOSE: Since, Leishmania protozoans are obligate intracellular parasites of macrophages, an immunopotentiating macrophage-specific Amphotericin B (AB) delivery system would be ideally appropriate to increase its superiority for leishmaniasis treatment and to eliminate undesirable toxicity. Herein, we report AB entrapped mannose grafted chitosan nanocapsules (MnosCNc-AB) that results in effective treatment of visceral leishmaniasis, while also enhancing L. donovani specific T-cell immune responses in infected host. METHODS: MnosCNc-AB were prepared via synthesized mannosylated chitosan deposition on interface of oil/water nanoemulsion intermediate and were characterized. J774A.1 macrophage uptake potential, antileishmanial activity and immunomodulatory profile were evaluated in hamster. Tissue localization, biodistribution and toxicity profile were also investigated. RESULTS: MnosCNc-AB had nanometric size (197.8 ± 8.84 nm), unimodal distribution (0.115 ± 0.04), positive zeta potential (+31.7 ± 1.03 mV) and 97.5 ± 1.13% cargo encapsulation efficiency. Superior macrophage internalization of mannosylated chitosan nanocapsules compared to unmodified chitosan nanocapsules was observed by fluorescence-based assessment, further confirmed by rapid blood clearance and, greater localization and higher accumulation in macrophage rich liver and spleen. While, MnosCNc-AB mediated cargo distribution to kidney decreased. Augmented in vitro antileishmanial activity and in vivo pro-inflammatory mediator's expression were observed with MnosCNc-AB, led to significant reduction (∼90%) in splenic parasite burden. CONCLUSIONS: Results demonstrated that mannose ligand grafted chitosan nanocapsules could improve selective delivery of AB into macrophages via interactions with overexpressed mannose receptors thus reduce undesirable toxicity. Study provides evidence for MnosCNc-AB potential to leishmaniasis therapeutics and presents valuable therapeutic strategies for combating chronic macrophage-resident microbial infections.


Subject(s)
Antiprotozoal Agents/pharmacology , Lectins, C-Type/drug effects , Macrophages/metabolism , Macrophages/parasitology , Mannose-Binding Lectins/drug effects , Receptors, Cell Surface/drug effects , Amphotericin B/administration & dosage , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/pharmacokinetics , Body Burden , Chemistry, Pharmaceutical , Cricetinae , Drug Compounding , Drug Delivery Systems , Leishmania donovani/drug effects , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/psychology , Mannose Receptor , Mesocricetus , Mice , Nanocapsules , Particle Size , Rats , Rats, Wistar , Spleen/parasitology , T-Lymphocytes/drug effects , T-Lymphocytes/parasitology , Tissue Distribution
6.
J Ethnopharmacol ; 124(3): 493-8, 2009 Jul 30.
Article in English | MEDLINE | ID: mdl-19467312

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: The seeds of Plantago asiatica L. were often used as a traditional Chinese medicine for some immunologically weak patients suffering from chronic illness. These uses could be related to immunomodulatory properties of the plant. AIM OF THE STUDY: In this study, effects of extract of the seeds of Plantago asiatica L. (ES-PL) were investigated on the maturation of dendritic cells (DCs), which play significant role in primary immune system. MATERIALS AND METHODS: The phenotypes of DCs were analyzed by using flow cytometry while phagocytosis was assessed by the uptake of FITC-dextran. Antigen presenting ability to allogeneically naïve or syngeneically primed T lymphocytes was examined by the lymphocyte proliferation of mixed lymphocyte reaction (MLR). In addition, the level of chemokine receptor CCR7 mRNA was determined by RT-PCR. RESULTS: DCs treated with ES-PL expressed higher levels of MHC class II molecules and major costimulatory molecules such as CD80 and CD86. Functional maturation of DCs treated with ES-PL was confirmed by decreased mannose receptor-mediated endocytosis and increased antigen presenting abilities to allogeneically naïve or syngeneically primed T lymphocytes. The CCR7 mRNA expression in DCs treated with ES-PL was also enhanced. CONCLUSIONS: These results indicated that ES-PL could induce the maturation of murine DCs.


Subject(s)
Immunologic Factors/pharmacology , Plantago/chemistry , Animals , Antigen-Presenting Cells/drug effects , Bone Marrow Cells/drug effects , Dendritic Cells/drug effects , Down-Regulation , Endocytosis/drug effects , Female , Flow Cytometry , Gene Expression/drug effects , Genes, MHC Class II/genetics , Immunologic Factors/chemistry , Lectins, C-Type/drug effects , Lymphocyte Culture Test, Mixed , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Plant Extracts/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Receptors, CCR7/biosynthesis , Receptors, CCR7/genetics , Receptors, Cell Surface/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Seeds/chemistry , Stimulation, Chemical
7.
Chem Biol Interact ; 179(2-3): 94-102, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19135433

ABSTRACT

Macrophages, the major phagocytes of body, are largely dependent on membrane for their apposite functioning. Cum-OOH, a catalyst used in chemical and pharmaceutical industry, is a peroxidative agent, which may induce oxidative stress in macrophages hampering the integrity of their membrane. Alpha-tocopherol is known to protect the membrane from oxidative modulation and preserve its integrity. In the present study, we investigated the effect of Cum-OOH on physiology of macrophages and evaluated the protective effect of alpha-tocopherol against Cum-OOH-induced functional impairment. An in vitro exposure to 10-200 microM Cum-OOH altered redox balance of murine peritoneal macrophages and led to a severe physiological impairment. It markedly augmented the release of proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-1beta and prostaglandin E(2)), lipopolysaccharide primed nitric oxide release and inducible nitric oxide synthase expression, and lysosomal hydrolases secretion. It mitigated respiratory burst and phagocytosis and intracellular killing of yeast (Saccharomyces cerevisiae). Mannose receptor, a major macrophage phagocytic receptor (also implicated in S. cerevisiae phagocytosis), exhibited a hampered recycling with its number being reduced to about 54% of the untreated, control cells following Cum-OOH exposure. A 24-h pretreatment of macrophages with 25 microM alpha-tocopherol preserved most of the assessed functions close to their corresponding control values. These data suggest that exposure to Cum-OOH may impair the physiology of immune cells such as macrophages and that supplementation with alpha-tocopherol can safeguard these cells against Cum-OOH toxicity.


Subject(s)
Benzene Derivatives/pharmacology , Macrophages/drug effects , Oxidative Stress/drug effects , alpha-Tocopherol/pharmacology , Animals , Benzene Derivatives/antagonists & inhibitors , Dinoprostone/metabolism , Dose-Response Relationship, Drug , Glucuronidase/metabolism , Glutathione/analysis , Interleukin-1beta/metabolism , Lectins, C-Type/drug effects , Macrophages/physiology , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Muramidase/metabolism , Oxygen/metabolism , Phagocytosis/drug effects , Rats , Rats, Wistar , Receptors, Cell Surface/drug effects , Saccharomyces cerevisiae/drug effects , Tumor Necrosis Factor-alpha/metabolism
8.
Am J Respir Crit Care Med ; 178(2): 139-48, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18420960

ABSTRACT

RATIONALE: Defective efferocytosis (phagocytic clearance of apoptotic cells) in the airway may perpetuate inflammation via secondary necrosis in chronic obstructive pulmonary disease (COPD). We have previously reported that low-dose azithromycin improved alveolar macrophage (AM) phagocytic function in vitro. OBJECTIVES: We investigated collectins (mannose-binding lectin [MBL] and surfactant protein [SP]-D) and mannose receptor (MR) in COPD and their possible role in the azithromycin-mediated improvement in phagocytosis. METHODS: In vitro effects of azithromycin on AM expression of MR were investigated. MBL, SP-D, and MR were measured in patients with COPD and control subjects. Azithromycin (250 mg orally daily for 5 d then twice weekly for 12 wk) was administered to 11 patients with COPD. Assessments included AM phagocytic ability and expression of MR, MBL, SP-D, bronchial epithelial cell apoptosis, pulmonary function, C-reactive protein, blood/BAL leukocyte counts, cytokine production, and T-cell markers of activation and phenotype. MEASUREMENTS AND MAIN RESULTS: Azithomycin (500 ng/ml) increased MR expression by 50% in vitro. AM MR expression and levels of MBL and SP-D were significantly reduced in patients with COPD compared with control subjects. In patients with COPD, after azithromycin therapy, we observed significantly improved AM phagocytic ability (pre: 9.9%; post: 15.1%), reduced bronchial epithelial cell apoptosis (pre: 30.0%; post: 19.7%), and increased MR and reduced inflammatory markers in the peripheral blood. These findings implicate the MR in the defective phagocytic function of AMs in COPD and as a target for the azithromycin-mediated improvement in phagocytic ability. CONCLUSIONS: Our findings indicate a novel approach to supplement existing therapies in COPD.


Subject(s)
Anti-Bacterial Agents/pharmacology , Azithromycin/pharmacology , Lectins, C-Type/drug effects , Macrophages, Alveolar/drug effects , Mannose-Binding Lectins/drug effects , Phagocytosis/drug effects , Pulmonary Disease, Chronic Obstructive/drug therapy , Receptors, Cell Surface/drug effects , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Apoptosis/drug effects , Azithromycin/administration & dosage , Azithromycin/therapeutic use , Bronchoalveolar Lavage Fluid/cytology , Case-Control Studies , Cells, Cultured , Collectins/drug effects , Collectins/metabolism , Female , Humans , Inflammation , Lectins, C-Type/metabolism , Male , Mannose Receptor , Mannose-Binding Lectins/metabolism , Middle Aged , Receptors, Cell Surface/metabolism , Respiratory Mucosa/drug effects , Respiratory Mucosa/metabolism , Statistics, Nonparametric
9.
Chem Biol Interact ; 171(3): 272-82, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18076871

ABSTRACT

The present study reports the antioxidant activity of ethanolic extract of Quercus infectoria galls. The antioxidant potency of galls was investigated employing several established in vitro model systems. Their protective efficacy on oxidative modulation of murine macrophages was also explored. Gall extract was found to contain a large amount of polyphenols and possess a potent reducing power. HPTLC analysis of the extract suggested it to contain 19.925% tannic acid (TA) and 8.75% gallic acid (GA). The extract potently scavenged free radicals including DPPH (IC(50)~0.5 microg/ml), ABTS (IC(50)~1 microg/ml), hydrogen peroxide (H(2)O(2)) (IC(50)~2.6 microg/ml) and hydroxyl (*OH) radicals (IC(50)~6 microg/ml). Gall extract also chelated metal ions and inhibited Fe(3+) -ascorbate-induced oxidation of protein and peroxidation of lipids. Exposure of rat peritoneal macrophages to tertiary butyl hydroperoxide (tBOOH) induced oxidative stress in them and altered their phagocytic functions. These macrophages showed elevated secretion of lysosomal hydrolases, and attenuated phagocytosis and respiratory burst. Activity of macrophage mannose receptor (MR) also diminished following oxidant exposure. Pretreatment of macrophages with gall extract preserved antioxidant armory near to control values and significantly protected against all the investigated functional mutilations. MTT assay revealed gall extract to enhance percent survival of tBOOH exposed macrophages. These results indicate that Q. infectoria galls possess potent antioxidant activity, when tested both in chemical as well as biological models.


Subject(s)
Antioxidants/pharmacology , Flavonoids/pharmacology , Macrophages/drug effects , Oxidative Stress/drug effects , Phenols/pharmacology , Plant Tumors , Quercus/chemistry , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Chromatography, Thin Layer/methods , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Flavonoids/chemistry , Flavonoids/isolation & purification , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/pharmacology , Gallic Acid/chemistry , Hydrolases/metabolism , Lectins, C-Type/drug effects , Lectins, C-Type/metabolism , Lipid Peroxidation/drug effects , Lysosomes/enzymology , Macrophages/metabolism , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mannose-Binding Lectins/metabolism , Mice , Phagocytosis/drug effects , Phagocytosis/physiology , Phenols/chemistry , Phenols/isolation & purification , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Polyphenols , Rats , Rats, Wistar , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/metabolism , Serum Albumin, Bovine/drug effects , Serum Albumin, Bovine/metabolism , Tannins/chemistry
10.
J Cell Physiol ; 210(2): 385-97, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17058260

ABSTRACT

Silibinin is the primary active compound in silymarin. It has been demonstrated to exert anti-carcinogenic effects and hepato-protective effects. However, the effects of silibinin on the maturation and immunostimulatory activities exhibited by dendritic cells (DCs) remain, for the most part, unknown. In this study, we have attempted to determine whether silibinin can influence surface molecule expression, dextran uptake, cytokine production, capacity to induce T-cell differentiation, and the signaling pathways underlying these phenomena in murine bone marrow-derived DCs. Silibinin was shown to significantly suppress the expression of CD80, CD86, MHC class I, and MHC class II in the DCs, and was also associated with impairments of LPS-induced IL-12 expression in the DCs. Silibinin-treated DCs proved highly efficient with regard to Ag capture via mannose receptor-mediated endocytosis. Silibinin also inhibited the LPS-induced activation of MAPKs and the nuclear translocation of the NF-kappaB p65 subunit. Additionally, silibinin-treated DCs evidenced an impaired induction of Th1 response, and a normal cell-mediated immune response. These findings provide new insight into the immunopharmacological functions of silibinin, especially with regard to their impact on the DCs. These findings expand our current understanding of the immunopharmacological functions of silibinin, and may prove useful in the development of therapeutic adjuvants for acute and chronic DC-associated diseases.


Subject(s)
Antigen Presentation/drug effects , Dendritic Cells/drug effects , Dermatitis, Contact/prevention & control , Immunity, Cellular/drug effects , T-Lymphocytes, Helper-Inducer/drug effects , Animals , Antigen Presentation/immunology , Antigens, Surface/drug effects , Antigens, Surface/immunology , Antigens, Surface/metabolism , Cell Differentiation/drug effects , Cell Differentiation/immunology , Cells, Cultured , Dendritic Cells/immunology , Dendritic Cells/metabolism , Dermatitis, Contact/immunology , Disease Models, Animal , Dose-Response Relationship, Drug , Endocytosis/drug effects , Endocytosis/immunology , Immunity, Cellular/immunology , Immunosuppression Therapy/methods , Immunosuppressive Agents/pharmacology , Interleukin-12/immunology , Interleukin-12/metabolism , Lectins, C-Type/drug effects , Lectins, C-Type/immunology , Lectins, C-Type/metabolism , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/immunology , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mannose-Binding Lectins/immunology , Mannose-Binding Lectins/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/immunology , Receptors, Cell Surface/metabolism , Silybin , Silymarin/pharmacology , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/metabolism , Th1 Cells/drug effects , Th1 Cells/immunology , Th1 Cells/metabolism , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/metabolism , Transcription Factor RelA/drug effects , Transcription Factor RelA/immunology , Transcription Factor RelA/metabolism
11.
Contraception ; 73(1): 97-101, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16371304

ABSTRACT

BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) exerts its contraceptive effect by interfering with sperm transport through the female genital tract and with ovulation. However, the possibility cannot be discarded that the device exerts a direct effect on sperm function, thus, helping prevent fertilization. OBJECTIVES: The purpose of this study is to evaluate whether LNG at doses comparable to that measured in the uterus during the use of the LNG-IUS affects the detection of D-mannose binding sites or zona pellucida (ZP) receptors on human spermatozoa. The association with acrosomal status was also investigated. METHODS: Seventeen semen samples from fertile men were used, and spermatozoa were separated using a Percoll gradient and incubated for 22 h at 37 degrees C under 5% CO(2) in air. Capacitated spermatozoa were exposed for 30 min to 1,000 or 10,000 ng/mL of LNG or control medium. D-Mannose binding sites were detected using commercial D-mannosylated bovine serum albumin conjugated with fluorescein isothiocyanate, and the percentage of specific patterns (II and III) was recorded. The acrosome reaction was evaluated using the Pisum sativum technique. RESULTS: Levonorgestrel releasing significantly increased (p < .001) the percentage of spermatozoa with D-mannose receptors localized in pattern III, and this increase was dose dependent and a significant increase (p < .001) in the percentage of acrosome-reacted spermatozoa. Double staining confirmed an association between the location of the zona receptor and acrosomal status. RESULTS: The in vitro exposure of capacitated spermatozoa to the assayed doses of LNG increased the proportion of spermatozoa with fewer chances of interacting with the ZP. Further studies should be carried out to confirm whether this mechanism is part of the contraceptive action of the LNG-IUS.


Subject(s)
Contraceptive Agents, Female/administration & dosage , Levonorgestrel/administration & dosage , Spermatozoa/drug effects , Uterus/drug effects , Zona Pellucida/metabolism , Acrosome Reaction/drug effects , Dose-Response Relationship, Drug , Female , Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescent Dyes , Humans , Lectins, C-Type/analysis , Lectins, C-Type/drug effects , Male , Mannose/metabolism , Mannose Receptor , Mannose-Binding Lectins/analysis , Mannose-Binding Lectins/drug effects , Receptors, Cell Surface/analysis , Receptors, Cell Surface/drug effects , Serum Albumin, Bovine , Sperm Capacitation , Spermatozoa/chemistry , Spermatozoa/metabolism
12.
Neurobiol Dis ; 20(3): 773-84, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15953732

ABSTRACT

Ethanol exposure induces retention of glycoproteins in growing astrocytes. We examined the intracellular sites at which this retention occurs and investigated whether this effect is accompanied by alterations in the Golgi complex and microtubular system. We studied the effects of ethanol on the Golgi complex structure, as well as on the secretory pathway functionality by monitoring both the transport of the VSV-G protein and the protein levels of several molecules involved in the regulation of this pathway. Ethanol was found to delay VSV-G transport, modify Golgi complex morphology, and reduce the number of secretory vesicles. Moreover, ethanol affected the levels of mannosidase II, p58, betaCOP, rbet1, and several Rab GTPases. It also affected microtubule organization and polymerization and the levels of the motor proteins kinesin and dynein. Most of these effects were dose-dependent. These alterations, together with those previously reported concerning biosynthesis of glycoconjugates, provide novel insights into how ethanol impairs brain development.


Subject(s)
Astrocytes/drug effects , Brain/drug effects , Brain/growth & development , Ethanol/toxicity , Golgi Apparatus/drug effects , Alcohol-Induced Disorders, Nervous System/metabolism , Alcohol-Induced Disorders, Nervous System/physiopathology , Animals , Astrocytes/metabolism , Brain/physiopathology , Cells, Cultured , Coatomer Protein/drug effects , Coatomer Protein/metabolism , Dose-Response Relationship, Drug , Female , Fetal Alcohol Spectrum Disorders/metabolism , Fetal Alcohol Spectrum Disorders/physiopathology , Golgi Apparatus/metabolism , Mannose-Binding Lectins/drug effects , Mannose-Binding Lectins/metabolism , Mannosidases/drug effects , Mannosidases/metabolism , Membrane Proteins/drug effects , Membrane Proteins/metabolism , Microtubules/drug effects , Microtubules/metabolism , Molecular Motor Proteins/drug effects , Molecular Motor Proteins/metabolism , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , Prenatal Exposure Delayed Effects/physiopathology , Qc-SNARE Proteins/drug effects , Qc-SNARE Proteins/metabolism , Rats , Secretory Vesicles/drug effects , Secretory Vesicles/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology , Vesicular Transport Proteins/drug effects , Vesicular Transport Proteins/metabolism , rab GTP-Binding Proteins/drug effects , rab GTP-Binding Proteins/metabolism
13.
J Vet Med Sci ; 67(1): 51-6, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15699594

ABSTRACT

In order to analyze the detailed mechanisms responsible for macrophage activation by chitin derivatives, resident peritoneal macrophages were prepared and stimulated with chitin, chitosan and low-molecular weight chitosan. Our findings were as follows: (i) chitosan induced apoptosis of peritoneal macrophages, but this did not occur when chitin or water soluble low-molecular weight chitosan were used; (ii) chitosan treatment induced activation markers, such as the major histocompatibility complex (MHC) class I, class II, Fc receptors, transferrin receptor, mannose receptor, Fas, and macrophage inflammatory protein (MIP)-2, whereas chitin and low molecular weight soluble chitosan induced only the expression of MHC class I and II molecules; (iii) apoptosis induced by chitosan was mediated by the Fas signaling pathway, in response to phagocytosis via the mannose receptor. We conclude that since chitosan activates macrophages, this may be the mechanism by which it accelerates wound healing.


Subject(s)
Chitin/pharmacology , Chitosan/pharmacology , Macrophage Activation/drug effects , Animals , Apoptosis/drug effects , Biomarkers/metabolism , Cells, Cultured , Glucans , Lectins, C-Type/drug effects , Lectins, C-Type/physiology , Macrophages, Peritoneal , Mannans/pharmacology , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mannose-Binding Lectins/physiology , Mice , Mice, Inbred Strains , Polysaccharides/pharmacology , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/physiology , Signal Transduction
14.
Pharmazie ; 59(5): 405-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15212310

ABSTRACT

The purpose of this study was to evaluate the effect of cationic charge of complexes after intravenous administration of cholesten-5-yloxy-N-[4-[(1-imino-2-D-thiomannosyl-ethyl)amino]butyl]formamide (Man-C4-Chol) containing cationic liposomes/pDNA complexes in mice. Transfection efficiency after intravenous administration of complex at a charge ratio (- : +) of 1.0:2.3 and/or 1.0:3.1 in liver and spleen expressing a mannose receptor on the cell surface were higher than those in lung. When complexes were formed at a charge ratio (- : +) of 1.0:4.7, on the other hand, transfection efficiency in the lung was highest, suggesting a non-specific interaction. Although asialoglycoprotein receptors are expressed on hepatocytes, a liver-selective gene transfection was not achieved by the intravenous administration of pDNA complexed with cholesten-5-yloxy-N-[4-[(1-imino-2-D-thiogalactosyl-ethyl)-amino]butyl]formamide (Gal-C4-Chol)/DOPE liposomes at a charge ratio (- : +) of 1.0 : 2.3. This information supports the design of pDNA/ligands-grafted cationic liposome complexes for cell-specific gene delivery after intravenous administration.


Subject(s)
Plasmids/genetics , Receptors, Drug/drug effects , Animals , Cations , Cells, Cultured , Chemical Phenomena , Chemistry, Physical , DNA/administration & dosage , DNA/genetics , Drug Carriers , Gene Expression , Injections, Intravenous , Lectins, C-Type/drug effects , Liposomes , Luciferases/genetics , Macrophages, Peritoneal/metabolism , Male , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mice , Mice, Inbred ICR , Particle Size , Plasmids/chemistry , Receptors, Cell Surface/drug effects , Transfection
15.
Pigment Cell Res ; 16(2): 149-58, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12622792

ABSTRACT

The 3beta-(2-diethylaminoethoxy)-androstenone HCl (U18666A), progesterone and several cationic amphiphilic drugs have been shown to alter the trafficking of a number of intracellular membrane proteins including CD63/Lamp-3, insulin growth factor 2/mannose 6-phosphate receptor (IGF2/MPR), and the Niemann-Pick C1 gene product (NPC1) as well as ganglioside GM1. We have examined the effects of these compounds on cultured melanocytes at concentrations that have been shown to effectively alter intracellular trafficking. Treatment of melanocytes with U18666A (2.5 micro M) or progesterone (15 micro M) for 96 h decreased melanin content an average of 67% as compared with control without lowering the total cellular tyrosinase activity. Steroidal alkaloids that preferentially act on the Sonic Hedgehog signaling pathway showed no related specificity in their ability to decrease pigmentation. In melanocytes treated with U18666A, tyrosinase accumulates in a compartment that contains both lysosome-associated membrane protein-1 (Lamp 1) and MPR, and stains with filipin, consistent with cholesterol-laden late endosomes/lysosomes. Our results suggest that tyrosinase, like the NPC1 gene product, traverses a U18666A-sensitive trafficking pathway.


Subject(s)
Cell Compartmentation/drug effects , Endosomes/enzymology , Epidermis/drug effects , Epidermis/enzymology , Lysosomes/enzymology , Melanocytes/drug effects , Melanocytes/enzymology , Monophenol Monooxygenase/drug effects , Androstenes/pharmacology , Animals , Antigens, CD/drug effects , Antigens, CD/metabolism , Carrier Proteins/drug effects , Carrier Proteins/metabolism , Cell Compartmentation/physiology , Cell Line, Transformed , Cholesterol/metabolism , Endosomes/drug effects , Enzyme Inhibitors/pharmacology , Epidermal Cells , Filipin , Intracellular Signaling Peptides and Proteins , Lectins, C-Type/drug effects , Lectins, C-Type/metabolism , Lysosomal Membrane Proteins , Lysosomes/drug effects , Mannose Receptor , Mannose-Binding Lectins/drug effects , Mannose-Binding Lectins/metabolism , Melanocytes/cytology , Membrane Glycoproteins/drug effects , Membrane Glycoproteins/metabolism , Mice , Monophenol Monooxygenase/metabolism , Niemann-Pick C1 Protein , Progesterone/pharmacology , Protein Transport/drug effects , Protein Transport/physiology , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...